Fundz

Theriva™ Biologics raises $4 million through a warrant incentive operation, intended for working capital and general corporate purposes.

PUBLIC · TOVXOct 16, 2025

Amount Raised

$4 Million

Round Type

Funding Round

RockvilleBiotechnologyHealth CareScience And EngineeringTherapeuticsBiopharma

Investors

A.G.P./Alliance Global Partners

Description

Theriva™ Biologics announced a warrant incentive agreement with current institutional investors for the immediate exercise of warrants to raise approximately $4 million. The proceeds will be used to increase working capital and for general corporate purposes. The offer will remain open until additional gross proceeds up to $400,000 are achieved. The closing is expected around October 17, 2025, pending customary closing conditions.

Quick answer

Theriva Biologics raised $4 Million in a Funding Round round, dated October 16, 2025. Investors: A.G.P./Alliance Global Partners. Theriva Biologics is based in Rockville, Maryland, United States.

How much did Theriva Biologics raise?
Theriva Biologics raised $4 Million in a Funding Round round on October 16, 2025.
Who invested in Theriva Biologics?
A.G.P./Alliance Global Partners is named as investors in this round.
What does Theriva Biologics do?
Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc. Theriva™ is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid..
Where is Theriva Biologics based and how big is it?
Theriva Biologics is based in Rockville, Maryland, United States. Fundz records about 22 employees.
Who are the decision-makers at Theriva Biologics?
Fundz holds 2 contacts at Theriva Biologics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Therapeutics around the same time

Companies in the same sectors as Theriva Biologics that raised within 45 days of this round, from Fundz verified event records.

  • BeyondSpring raised $2M (Funding Round) on November 21, 2025.
  • GenSight Biologics raised $2.3M (Funding Round) on November 10, 2025.
  • Acasti raised $4M (Funding Round) on October 23, 2025.
  • Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
  • ISOThrive raised $8.1M on October 10, 2025.
  • TORL BioTherapeutics raised $96M (Series C) on October 7, 2025.

Who to call at Theriva Biologics, and when

A new round usually means Theriva Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Theriva Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Theriva Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Theriva Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Theriva Biologics

Location

Rockville, Maryland, United States

About

Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc. Theriva™ is a clinical-stage immuno-oncology company developing oncolytic viruses intended to overcome the protective barrier surrounding solid tumors and selectively kill tumor cells. Our developmental therapies stem from the laboratory of Dr. Ramon Alemany, recognized world-wide as a key opinion leader in adenovirus technologies, and are designed to enable systemic delivery and have the potential to enhance current standard-of-care treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Theriva Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts10 people are listed at Theriva Biologics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Theriva Biologics's next move

See what Strategic adds

Theriva Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.